These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

291 related items for PubMed ID: 7193028

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Effects of isoniazid on hepatic drug oxidation and N-acetylation capacities in rats.
    Desta Z, Siegmund W, Franke G, Beyrich A, Bleyer H.
    Pharmazie; 1992 Jun; 47(6):448-51. PubMed ID: 1409842
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Pharmacokinetics of the toxic hydrazino metabolites formed from isoniazid in humans.
    Lauterburg BH, Smith CV, Todd EL, Mitchell JR.
    J Pharmacol Exp Ther; 1985 Dec; 235(3):566-70. PubMed ID: 4078724
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Determination of isoniazid half-life from salivary samples.
    Suryawati S, Santoso B.
    Int J Clin Pharmacol Ther Toxicol; 1986 Jan; 24(1):18-22. PubMed ID: 3957485
    [Abstract] [Full Text] [Related]

  • 9. Polymorphic N-acetylation of sulfamethazine and benzidine by human liver: implication for cancer risk?
    Peters JH, Gordon GR, Lin E, Green CE, Tyson CA.
    Anticancer Res; 1990 Jan; 10(1):225-9. PubMed ID: 2334132
    [Abstract] [Full Text] [Related]

  • 10. N-acetylation of drugs. Pharmacogenetic studies in rabbits selected for their acetylator characteristics.
    Weber WW, Miceli JN, Hearse DJ, Drummond GS.
    Drug Metab Dispos; 1976 Jan; 4(1):94-101. PubMed ID: 3408
    [Abstract] [Full Text] [Related]

  • 11. [Biotransformation of phenazone and sulfadimidine as markers of liver metabolism of drug and xenobiotic oxidation and acetylation in women with breast cancer].
    Orzechowska-Juzwenko K, Wiela-Hojeńska A, Milejski P, Cieślińska A, Hudziec P, Adamska M.
    Przegl Lek; 1997 Jan; 54(2):103-6. PubMed ID: 9198818
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Comparison between serum and urinary sulphadimidine acetylation as predictors of isoniazid acetylator status in patients with pulmonary tuberculosis.
    Singh SP, Pande JN, Khilnani GC, Kailash S.
    Indian J Chest Dis Allied Sci; 1996 Jan; 38(1):5-11. PubMed ID: 16892742
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Pharmacokinetics, metabolism, and renal excretion of sulfadimidine and its N4-acetyl and hydroxy metabolites in humans.
    Vree TB, Hekster YA, Nouws JF, Baakman M.
    Ther Drug Monit; 1986 Jan; 8(4):434-9. PubMed ID: 3824429
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. N-acetylation phenotyping with sulfamethazine in an Iranian population.
    Sardaş S, Lahijany B, Cok I, Karakaya AE.
    Pharmacogenetics; 1993 Jun; 3(3):131-4. PubMed ID: 8334437
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.